ATE207744T1 - Neue verwendung von omega-3-fettsäuren - Google Patents

Neue verwendung von omega-3-fettsäuren

Info

Publication number: ATE207744T1
Authority: AT; Austria
Prior art keywords: omega; pct; preparations; fatty acids; dic
Prior art date: 1992-02-24

Application number

AT93905710T

Other languages

English (en)

Inventor

Nils Egberg

Carin Larsson-Backstroem

Jan Jakobsson

Rolf Lundh

Original Assignee

Fresenius Kabi Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-24

Filing date

1993-02-23

Publication date

2001-11-15

1993-02-23 Application filed by Fresenius Kabi Ab filed Critical Fresenius Kabi Ab

2001-11-15 Application granted granted Critical

2001-11-15 Publication of ATE207744T1 publication Critical patent/ATE207744T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Emergency Medicine (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Marine Sciences & Fisheries (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

AT93905710T 1992-02-24 1993-02-23 Neue verwendung von omega-3-fettsäuren ATE207744T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9200541A SE9200541D0 (sv)	1992-02-24	1992-02-24	New usee of omega-3-fatty acids
PCT/SE1993/000146 WO1993016691A1 (en)	1992-02-24	1993-02-23	New use of omega-3-fatty acids

Publications (1)

Publication Number	Publication Date
ATE207744T1 true ATE207744T1 (de)	2001-11-15

Family

ID=20385410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93905710T ATE207744T1 (de)	1992-02-24	1993-02-23	Neue verwendung von omega-3-fettsäuren

Country Status (13)

Country	Link
US (2)	US5747533A (de)
EP (1)	EP0627918B1 (de)
JP (1)	JP3559280B2 (de)
AT (1)	ATE207744T1 (de)
AU (1)	AU671438B2 (de)
CA (1)	CA2117535A1 (de)
DE (1)	DE69331051T2 (de)
DK (1)	DK0627918T3 (de)
ES (1)	ES2162620T3 (de)
NO (1)	NO309704B1 (de)
SE (1)	SE9200541D0 (de)
SG (1)	SG46238A1 (de)
WO (1)	WO1993016691A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0987176A (ja) *	1995-09-26	1997-03-31	Shiseido Co Ltd	糸球体腎炎抑制剤
EP1004303B1 (de) *	1997-06-16	2004-10-13	Nippon Suisan Kaisha, Ltd.	Zusammensetzung zum vermeiden von risikofaktoren beim sporttraining
US6054481A (en)	1998-01-21	2000-04-25	Fideline	Pig appeasing pheromones for enhancing weight gain in a mammal
JP4754688B2 (ja) *	1998-01-21	2011-08-24	フィドゥラン	ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
US6077867A (en) *	1998-01-21	2000-06-20	Fideline	Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
EP1220669A4 (de) *	1999-10-13	2004-12-08	Marco A Chacon	THERAPEUTISCHE MASSNAHME, UM DEN EFFEKT EINER KALORIENBESCHRäNKUNG NACHZUAHMEN
FR2804023B1 (fr) *	2000-01-26	2002-09-20	Johnson & Johnson Consumer Fr	Complement nutritionnel a base d'huile de pepins de cassis
WO2002069964A1 (en) *	2001-03-05	2002-09-12	Ernest Stephen P	Enteral formulation
US8729124B2 (en) *	2002-03-05	2014-05-20	Pronova Biopharma Norge As	Use of EPA and DHA in secondary prevention
US7323206B1 (en)	2003-03-04	2008-01-29	B. Braun Medical Inc.	Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US9801982B2 (en)	2004-09-28	2017-10-31	Atrium Medical Corporation	Implantable barrier device
WO2006036984A2 (en)	2004-09-28	2006-04-06	Atrium Medical Corporation	Stand-alone film and methods for making the same
US9012506B2 (en)	2004-09-28	2015-04-21	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US9000040B2 (en)	2004-09-28	2015-04-07	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US20060088596A1 (en)	2004-09-28	2006-04-27	Atrium Medical Corporation	Solubilizing a drug for use in a coating
US20060135610A1 (en) *	2004-12-22	2006-06-22	Bortz Jonathan D	Cardiovascular compositions
EP1896059B1 (de) *	2005-06-24	2012-12-19	Drugrecure ApS	Atemwegs-administration eines gewebefaktorweghemmers bei entzündungskrankheiten, die den atemtrakt betreffen
US9278161B2 (en)	2005-09-28	2016-03-08	Atrium Medical Corporation	Tissue-separating fatty acid adhesion barrier
US9427423B2 (en)	2009-03-10	2016-08-30	Atrium Medical Corporation	Fatty-acid based particles
CA2641852A1 (en) *	2006-02-10	2007-08-16	Sportscom Danmark Aps	Coated tablets, their methods of preparation, and related uses
WO2008057344A2 (en)	2006-11-06	2008-05-15	Atrium Medical Corporation	Coated surgical mesh
US9492596B2 (en)	2006-11-06	2016-11-15	Atrium Medical Corporation	Barrier layer with underlying medical device and one or more reinforcing support structures
US20080207756A1 (en) *	2007-02-27	2008-08-28	Atrium Medical Corporation	Bio-absorbable oil suspension
WO2009052182A1 (en)	2007-10-15	2009-04-23	Jbs United, Inc.	Method for increasing performance of offspring
WO2009009040A2 (en) *	2007-07-06	2009-01-15	Baum Seth J	Fatty acid compositions and methods of use
WO2009058799A1 (en) *	2007-11-01	2009-05-07	Wake Forest University School Of Medicine	Compositions and methods for prevention and treatment of mammalian diseases
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20100323028A1 (en) *	2007-11-30	2010-12-23	Jbs United, Inc.	Method and composition for treating pulmonary hemorrhage
US20110038910A1 (en)	2009-08-11	2011-02-17	Atrium Medical Corporation	Anti-infective antimicrobial-containing biomaterials
US20110045050A1 (en) *	2009-08-24	2011-02-24	Atrium Medical Corporation	Nanoemulsion formulations for direct delivery
WO2011103514A1 (en) *	2010-02-18	2011-08-25	Martek Biosciences Corporation	Dha triglyceride emulsions
US20110200645A1 (en) *	2010-02-18	2011-08-18	Martek Biosciences Corporation	DHA Free Fatty Acid Emulsions
EP2593141B1 (de)	2010-07-16	2018-07-04	Atrium Medical Corporation	Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis
US20210176999A1 (en)	2011-04-17	2021-06-17	Omega Foods, LLC	Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US9867880B2 (en)	2012-06-13	2018-01-16	Atrium Medical Corporation	Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9233114B2 (en)	2013-12-05	2016-01-12	Buriva, LLC	Dietary supplement containing phospholipid-DHA derived from eggs
US9549937B2 (en)	2013-12-05	2017-01-24	Burvia, LLC.	Composition containing phospholipid-DHA and folate
US9216199B2 (en)	2013-12-05	2015-12-22	Buriva, LLC	Nutritional supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en)	2013-12-05	2017-04-04	Buriva, LLC.	Composition containing phospholipid-DHA and B vitamins
US10183044B2 (en) *	2015-05-15	2019-01-22	P Tech, Llc	Systems and methods for thrombosis prevention
US9655847B1 (en) *	2016-07-18	2017-05-23	National Guard Health Affairs	Therapeutic liposome and method of treating a subject having cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4752618A (en) *	1984-07-12	1988-06-21	New England Deaconess Hospital	Method of minimizing efects of infection through diet
US4678808A (en) *	1985-10-15	1987-07-07	Baxter Travenol Laboratories, Inc.	Rapid acting intravenous emulsions of omega-3 fatty acid esters
DE3785667T2 (de) *	1986-09-17	1994-07-21	Clintec Nutrition Co	Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
DE3719097C1 (de) *	1987-06-06	1988-06-09	Fratzer Uwe	Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
GB8729751D0 (en) *	1987-12-21	1988-02-03	Norsk Hydro As	Feed additive & feed containing such additive
GB8819110D0 (en) *	1988-08-11	1988-09-14	Norsk Hydro As	Antihypertensive drug & method for production
US5223285A (en) *	1992-03-31	1993-06-29	Abbott Laboratories	Nutritional product for pulmonary patients

1992
- 1992-02-24 SE SE9200541A patent/SE9200541D0/xx unknown
1993
- 1993-02-23 WO PCT/SE1993/000146 patent/WO1993016691A1/en active IP Right Grant
- 1993-02-23 SG SG1996001422A patent/SG46238A1/en unknown
- 1993-02-23 JP JP51475493A patent/JP3559280B2/ja not_active Expired - Lifetime
- 1993-02-23 AU AU36529/93A patent/AU671438B2/en not_active Ceased
- 1993-02-23 DK DK93905710T patent/DK0627918T3/da active
- 1993-02-23 EP EP93905710A patent/EP0627918B1/de not_active Expired - Lifetime
- 1993-02-23 AT AT93905710T patent/ATE207744T1/de active
- 1993-02-23 DE DE69331051T patent/DE69331051T2/de not_active Expired - Lifetime
- 1993-02-23 CA CA002117535A patent/CA2117535A1/en not_active Abandoned
- 1993-02-23 ES ES93905710T patent/ES2162620T3/es not_active Expired - Lifetime
- 1993-02-23 US US08/290,905 patent/US5747533A/en not_active Expired - Lifetime
1994
- 1994-08-23 NO NO943102A patent/NO309704B1/no not_active IP Right Cessation
1995
- 1995-06-07 US US08/483,977 patent/US5731346A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO309704B1 (no)	2001-03-19
US5747533A (en)	1998-05-05
NO943102D0 (no)	1994-08-23
AU671438B2 (en)	1996-08-29
SG46238A1 (en)	1998-02-20
ES2162620T3 (es)	2002-01-01
DE69331051D1 (de)	2001-12-06
NO943102L (no)	1994-10-21
DE69331051T2 (de)	2002-06-13
EP0627918B1 (de)	2001-10-31
WO1993016691A1 (en)	1993-09-02
JP3559280B2 (ja)	2004-08-25
AU3652993A (en)	1993-09-13
EP0627918A1 (de)	1994-12-14
JPH07507766A (ja)	1995-08-31
CA2117535A1 (en)	1993-09-02
US5731346A (en)	1998-03-24
SE9200541D0 (sv)	1992-02-24
DK0627918T3 (da)	2002-01-14

Publication	Publication Date	Title
ATE207744T1 (de)	2001-11-15	Neue verwendung von omega-3-fettsäuren
ATE216227T1 (de)	2002-05-15	Phospholipide
FR2762993B1 (fr)	1999-08-13	Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
PT1229800E (pt)	2005-11-30	Emulsao contendo agua e oleo
FI964332A (fi)	1996-10-28	Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
DE50012804D1 (de)	2006-06-29	Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
ATE142884T1 (de)	1996-10-15	Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen
Brown et al.	1991	Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs
ATE73996T1 (de)	1992-04-15	Verwendung lang- und mittelkettiger triglyzeride.
DE59002572D1 (de)	1993-10-07	Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung.
AU600502B2 (en)	1990-08-16	Body lubricating and cleansing fluid
SE8801710L (sv)	1988-11-08	New ophtalmological composition of matter
DE69005459D1 (de)	1994-02-03	Anreicherungsverfahren der fette an polyungesättigten fettsäuren und phospholipiden und anwendung dieser angereicherten fette.
DE58906606D1 (de)	1994-02-17	Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
DK0746551T3 (da)	2003-01-06	Optisk rene 4-aryl-2-hydroxytetronsyrer
FR2603587A1 (fr)	1988-03-11	Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires
ES2074264T3 (es)	1995-09-01	Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
Saravanan et al.	2007	Inhibitory effect of Hemidesmus indicus and its active principle 2‐hydroxy 4‐methoxy benzoic acid on ethanol‐induced liver injury
NO975155L (no)	1997-11-10	Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet
JPS57209218A (en)	1982-12-22	Antithrombotic
KR940011003A (ko)	1994-06-20	우르솔린산을 함유하는 혈관형성 억제제 조성물
ATE99692T1 (de)	1994-01-15	Optisch aktive rhodiumkomplexe von 3,4bis(diarylphosphino)-pyrrolidinen und ihre verwendung zur herstellung von phosphinothricin durch asymmetrische hydrierung.
Desmond	1983	" Huckleberry Finn" and the Failure of Anamnesis
Paul et al.	1976	DISCUSSION ON DR. DAWBER'S PAPER (The Interrelationship of Tobacco Smoke Components to Hyperlipidemia and Other Risk Factors)
ATE312611T1 (de)	2005-12-15	Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date	Code	Title	Description
2002-02-15	UEP	Publication of translation of european patent specification